Merus Labs

 engages in acquiring and licensing pharmaceutical drugs that cures oncology, cardiovascular and infectious diseases...
Read more
Merus Labs CEO: Barry Fishman

CEO

Barry Fishman

CEO Approval Rating

69/100

Est. Annual Revenue
$25-100M
Agree?
Est. Employees
1-25
Agree?
Funding
$20M

News

Jun 12, 2020
European Biotechnology
Merus Labs: Norgine to acquire Merus
Oct 01, 2018
PR Newswire
Press Release: Merus Labs : Norgine B.V. to Divest Its Canadian Assets Acquired Through Merus Labs International Inc. to Searchlight Pharma
Sep 30, 2018
BioPortfolio
Merus Labs: Merus Labs International Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27082018 Prices from USD $250
Aug 02, 2018
BioPortfolio
Merus Labs: Merus Labs International Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Jun 07, 2018
BioPortfolio
Merus Labs: Merus Labs International Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250
Mar 15, 2018
BioPortfolio
Merus Labs: Merus Labs International Inc MSL Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300
Dec 13, 2017
BioPortfolio
Merus Labs: Merus Labs International Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15112017 Prices from USD $250
Nov 26, 2017
BioPortfolio
Merus Labs: Merus Labs International Inc MSL Financial and Strategic SWOT Analysis Review Report Updated 13112017 Prices from USD $300
Aug 31, 2017
BioPortfolio
Merus Labs: Merus Labs International Inc MSL Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 22082017 Prices from USD $250
Aug 10, 2017
BioPortfolio
Merus Labs: Merus Labs International Inc MSL Financial and Strategic SWOT Analysis Review Report Updated 07082017 Prices from USD $300

Merus Labs Competitors

1argenx
2Acerus
3Amgen
4AbbVie
5GSK
6Biogen
7Roche
8EndoCeutics
9Lipocine
10Telesta Therapeutics

Trending Companies